Ignite Creation Date:
2024-05-06 @ 2:49 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04433546
Status:
TERMINATED
Last Update Posted:
2020-12-11
First Post:
2020-05-28
Brief Title:
Pemziviptadil PB1046 a Long-acting Sustained Release Human VIP Analogue Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome ARDS
Sponsor:
PhaseBio Pharmaceuticals Inc
Organization:
PhaseBio Pharmaceuticals Inc
Organization Data
Organization:
PhaseBio Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
PB1046-PT-CL-0007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PhaseBio Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None